SRATI 2022

THE 48TH CONGRESS OF THE ROMANIAN SOCIETY OF ANAESTHESIA AND INTENSIVE CARE

THE 16TH ROMANIAN-FRENCH CONGRESS OF ANAESTHESIA AND INTENSIVE CARE
THE 14TH ROMANIAN-ISRAELI SYMPOSIUM ON UPDATES IN  ANAESTHESIA AND INTENSIVE CARE
THE 21ST CONGRESS OF ANAESTHESIA AND INTENSIVE CARE NURSES
THE 9TH SYMPOSIUM OF THE ROMANIAN AND MOLDAVIAN SOCIETIES OF ANAESTHESIA AND INTENSIVE CARE

11 - 15 MAY 2022
HYBRID Event
v-SRATI 2022 Platform & International Conference Center, Sinaia

TAKEDA PHARMACEUTICALS


City Gate, South Tower 3-5, Piața Presei Libere Street, 15th Floor, 013702 -Bucharest, 1st District, Romania
Tel.: 0040 - 37 - 247.41.75
Fax: 0040 - 21 - 335.03.04

 

Takeda Pharmaceutical Company Limited (TSE: 4502/NYSE: TAK) is a global, values-based, R&D-driven biopharmaceutical leader headquartered in Japan, committed to discover and deliver life-transforming treatments, guided by our commitment to patients, our people and the planet.

Takeda focuses its R&D efforts on four therapeutic areas: Oncology, Rare Genetics and Hematology, Neuroscience, and Gastroenterology (GI). We also make targeted R&D investments in Plasma-Derived Therapies and Vaccines.

We are focusing on developing highly innovative medicines that contribute to making a difference in people’s lives by advancing the frontier of new treatment options and leveraging our enhanced collaborative R&D engine and capabilities to create a robust, modality-diverse pipeline.

Our employees are committed to improving quality of life for patients and to working with our partners in health care in approximately 80 countries and regions. 

For more informatios, visit us at www.takeda.com